Analysed IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) News Sources
IDEAYA Biosciences to Initiate New Drug Application Submission from the Darovasertib OptimUM-02 Trial under the Oncology Center of Excellence Real-time Oncology Review (RTOR) Program
30-04-2026
yahoo.com
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01-05-2026
yahoo.com
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
05-05-2026
yahoo.com
Assessing IDEAYA Biosciences (IDYA) Valuation After Positive Darovasertib Phase 2/3 Results And FDA Real-Time Review
07-05-2026
yahoo.com
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data
18-05-2026
marketbeat.com
IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing
25-05-2026
marketbeat.com
IDEAYA Biosciences Announces Participation at the 2026 Jefferies Global Healthcare Conference
26-05-2026
yahoo.com
What is the current price of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?
The current price of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is $28.99.
IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) absolute price change since previous trading day?
The absolute price change of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) since the previous trading day is $-0.29.
IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) percentage price change since previous trading day?
The percentage price change of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) since the previous trading day is -0.9904%.
What is the most recent average sentiment score for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?
The most recent average sentiment score for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?
The most recent sentiment for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is .
SEC-8K** Filing Available For IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.